Estey E, Hasserjian RP and Döhner H: Distinguishing AML from MDS: A fixed blast percentage may no longer be optimal. Blood. 139:323–332. 2022.PubMed/NCBI View Article : Google Scholar

Bispo JAB, Pinheiro PS and Kobetz EK: Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 10(a034819)2020.PubMed/NCBI View Article : Google Scholar

Rausch C, Rothenberg-Thurley M, Dufour A, Schneider S, Gittinger H, Sauerland C, Görlich D, Krug U, Berdel WE, Woermann BJ, et al: Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia. Leukemia. 37:1234–1244. 2023.PubMed/NCBI View Article : Google Scholar

Li Y, Yang W, Devidas M, Winter SS, Kesserwan C, Yang W, Dunsmore KP, Smith C, Qian M, Zhao X, et al: Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia. J Clin Invest. 131(e147898)2021.PubMed/NCBI View Article : Google Scholar : (Epub ahead of print).

Voulgaris E, Pentheroudakis G and Pavlidis N: Cancer and pregnancy: A comprehensive review. Surg Oncol. 20:e175–e185. 2011.PubMed/NCBI View Article : Google Scholar

Thomas X: Acute myeloid leukemia in the pregnant patient. Eur J Haematol. 95:124–136. 2015.PubMed/NCBI View Article : Google Scholar

Zhu D, Tang D, Chai X, Zhang G and Wang Y: Acute leukemia in pregnancy: A single institutional experience with 21 cases at 10 years and a review of the literature. Ann Med. 53:567–575. 2021.PubMed/NCBI View Article : Google Scholar

Ali S, Jones GL, Culligan DJ, Marsden PJ, Russell N, Embleton ND and Craddock C: British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. Br J Haematol. 170:487–495. 2015.PubMed/NCBI View Article : Google Scholar

Grove CS and Vassiliou GS: Acute myeloid leukaemia: A paradigm for the clonal evolution of cancer? Dis Model Mech. 7:941–951. 2014.PubMed/NCBI View Article : Google Scholar

Lavudi K, Nuguri SM, Olverson Z, Dhanabalan AK, Patnaik S and Kokkanti RR: Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers. Front Cell Dev Biol. 11(1254612)2023.PubMed/NCBI View Article : Google Scholar

Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM and Tallman MS: Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid. Blood. 118:1248–1254. 2011.PubMed/NCBI View Article : Google Scholar

Tsuda H, Doi H, Inada T and Shirono K: Successful treatment of acute promyelocytic leukemia in a pregnant woman by using all-trans retinoic acid. Rinsho Ketsueki. 35:717–719. 1994.PubMed/NCBI(In Japanese).

Sanz MA, Fenaux P, Tallman MS, Estey EH, Löwenberg B, Naoe T, Lengfelder E, Döhner H, Burnett AK, Chen SJ, et al: Management of acute promyelocytic leukemia: Updated recommendations from an expert panel of the European LeukemiaNet. Blood. 133:1630–1643. 2019.PubMed/NCBI View Article : Google Scholar

Santolaria A, Perales A, Montesinos P and Sanz MA: Acute promyelocytic leukemia during pregnancy: A systematic review of the literature. Cancers (Basel). 12(968)2020.PubMed/NCBI View Article : Google Scholar

Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, Naoe T, Lengfelder E, Büchner T, Döhner H, et al: Management of acute promyelocytic leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 113:1875–1891. 2009.PubMed/NCBI View Article : Google Scholar

Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, Girardi F, Fowler C, Marcos-Gragera R, Bonaventure A, et al: Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): Analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health. 6:409–431. 2022.PubMed/NCBI View Article : Google Scholar

DeRenzo C, Krenciute G and Gottschalk S: The landscape of CAR T cells beyond acute lymphoblastic leukemia for pediatric solid tumors. Am Soc Clin Oncol Educ Book. 38:830–837. 2018.PubMed/NCBI View Article : Google Scholar

Chiaretti S, Zini G and Bassan R: Diagnosis and subclassification of acute lymphoblastic leukemia. Mediterr J Hematol Infect Dis. 6(e2014073)2014.PubMed/NCBI View Article : Google Scholar

Ticku J, Oberoi S, Friend S, Busowski J, Langenstroer M and Baidas S: Acute lymphoblastic leukemia in pregnancy: A case report with literature review. Ther Adv Hematol. 4:313–319. 2013.PubMed/NCBI View Article : Google Scholar

Farhadfar N, Cerquozzi S, Hessenauer MR, Litzow MR, Hogan WJ, Letendre L, Patnaik MM, Tefferi A and Gangat N: Acute leukemia in pregnancy: A single institution experience with 23 patients. Leuk Lymphoma. 58:1052–1060. 2017.PubMed/NCBI View Article : Google Scholar

Nadeem S, Elahi E, Iftikhar I, Umar S, Ahsan B, Ahmad U and Bokhari SW: Management of acute lymphoblastic leukemia during pregnancy: A case report and review of the literature. Cureus. 16(e52489)2024.PubMed/NCBI View Article : Google Scholar

Theodora M, Theofanakis C, Fasoulakis ZN, Barbarousi D, Daskalakis G and Rodolakis A: EP685 Management of acute lymphoblastic leukemia in a 26-year-old primigravida. Int J Gynecol Cancer. 29 (Suppl 4):A392.3–A393. 2019.

Vlijm-Kievit A, Jorna NGE, Moll E, Pajkrt E, Pals ST, Middeldorp S, Biemond BJ, Zeerleder SS, Tio MA, Kemper EM and Hazenberg MD: Acute lymphoblastic leukemia during the third trimester of pregnancy. Leuk Lymphoma. 59:1274–1276. 2018.PubMed/NCBI View Article : Google Scholar

Romero-Morelos P, González-Yebra AL, Muñoz-López D, Lara-Lona E and González-Yebra B: Frequencies of BCR::ABL1 transcripts in patients with chronic myeloid leukemia: A meta-analysis. Genes (Basel). 15(232)2024.PubMed/NCBI View Article : Google Scholar

American Cancer Society: Risk Factors for Chronic Myeloid Leukemia. https://www.cancer.org/cancer/types/chronic-myeloid-leukemia/causes-risks-prevention/risk-factors.html.

Zhao D, Long X and Wang J: Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: A safety analysis of the FDA adverse event reporting system. BMC Pharmacol Toxicol. 25(20)2024.PubMed/NCBI View Article : Google Scholar

Brehme M, Koschmieder S, Montazeri M, Copland M, Oehler VG, Radich JP, Brümmendorf TH and Schuppert A: Combined population dynamics and entropy modelling supports patient stratification in chronic myeloid leukemia. Sci Rep. 6(24057)2016.PubMed/NCBI View Article : Google Scholar

Xue M, Wang Q, Huo L, Wen L, Yang X, Wu Q, Pan J, Cen J, Ruan C, Wu D and Chen S: Clinical characteristics and prognostic significance of chronic myeloid leukemia with rare BCR-ABL1 transcripts. Leuk Lymphoma. 60:3051–3057. 2019.PubMed/NCBI View Article : Google Scholar

Yadav U, Solanki SL and Yadav R: Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery. J Cancer Res Ther. 9:484–486. 2013.PubMed/NCBI View Article : Google Scholar

Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, Rosti G and Apperley JF: The effects of imatinib on pregnancy outcome. Blood. 111:5505–5508. 2008.PubMed/NCBI View Article : Google Scholar

Abruzzese E, Mauro M, Apperley J and Chelysheva E: Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: Opinion, evidence, and recommendations. Ther Adv Hematol. 11(2040620720966120)2020.PubMed/NCBI View Article : Google Scholar

Soverini S, De Benedittis C, Mancini M and Martinelli G: Best practices in chronic myeloid leukemia monitoring and management. Oncologist. 21:626–633. 2016.PubMed/NCBI View Article : Google Scholar

Zhang S and Kipps TJ: The pathogenesis of chronic lymphocytic leukemia. Annu Rev Pathol. 9:103–118. 2014.PubMed/NCBI View Article : Google Scholar

Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, O'Brien S, Gribben J and Rai K: Chronic lymphocytic leukaemia. Nat Rev Dis Primers. 3(16096)2017.PubMed/NCBI View Article : Google Scholar

Rogers A and Woyach JA: BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naive elderly patients with CLL. Ther Adv Hematol. 11(2040620720912990)2020.PubMed/NCBI View Article : Google Scholar

Hamad N, Kliman D, Best OG, Caramins M, Hertzberg M, Lindeman R, Porter R and Mulligan SP: Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: Five cases, a literature review and discussion of management. Br J Haematol. 168:350–360. 2015.PubMed/NCBI View Article : Google Scholar

Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, et al: Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International workshop on chronic lymphocytic leukemia updating the national cancer institute-working group 1996 guidelines. Blood. 111:5446–5456. 2008.PubMed/NCBI View Article : Google Scholar

Luttwak E, Gurevich-Shapiro A, Azem F, Lishner M, Klieger C, Herishanu Y, Perry C and Avivi I: Novel agents for the treatment of lymphomas during pregnancy: A comprehensive literature review. Blood Rev. 49(100831)2021.PubMed/NCBI View Article : Google Scholar

Daver N, Nazha A, Kantarjian HM, Haltom R and Ravandi F: Treatment of hairy cell leukemia during pregnancy: Are purine analogues and rituximab viable therapeutic options. Clin Lymphoma Myeloma Leuk. 13:86–89. 2013.PubMed/NCBI View Article : Google Scholar

Cannon T, Mobarek D, Wegge J and Tabbara IA: Hairy cell leukemia: Current concepts. Cancer Invest. 26:860–865. 2008.PubMed/NCBI View Article : Google Scholar

Munir F, Hardit V, Sheikh IN, AlQahtani S, He J, Cuglievan B, Hosing C, Tewari P and Khazal S: Classical Hodgkin lymphoma: from past to future-A comprehensive review of pathophysiology and therapeutic advances. Int J Mol Sci. 24(10095)2023.PubMed/NCBI View Article : Google Scholar

Mazharul M: Complications and Pathophysiology of Hodgkin Lymphoma. J Hematol Thrombo Dis. 10(515)2023.

American Cancer Society: Hodgkin Lymphoma Risk Factors, Risk Factors for Hodgkin Disease. https://www.cancer.org/cancer/types/hodgkin-lymphoma/causes-risks-prevention/risk-factors.html.

Smith LH, Danielsen B, Allen ME and Cress R: Cancer associated with obstetric delivery: Results of linkage with the California cancer registry. Am J Obstet Gynecol. 189:1128–1135. 2003.PubMed/NCBI View Article : Google Scholar

Connors JM: Clinical manifestations and natural history of Hodgkin's lymphoma. Cancer J. 15:124–128. 2009.PubMed/NCBI View Article : Google Scholar

Bachanova V and Connors JM: Hodgkin lymphoma in pregnancy. Curr Hematol Malig Rep. 8:211–217. 2013.PubMed/NCBI View Article : Google Scholar

Gurevich-Shapiro A and Avivi I: Current treatment of lymphoma in pregnancy. Expert Rev Hematol. 12:449–459. 2019.PubMed/NCBI View Article : Google Scholar

Borchmann P, Eichenauer DA and Engert A: State of the art in the treatment of Hodgkin lymphoma. Nat Rev Clin Oncol. 9:450–459. 2012.PubMed/NCBI View Article : Google Scholar

Ciccarone M, Cavaceppi P, Tesei C, Brunetti S, Pulsoni A, Annibali O, Gasparoli C, Battistini R, Hohaus S, Pelliccia S, et al: Effects of ABVD chemotherapy on ovarian function: Epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's disease. Front Oncol. 13(1059393)2023.PubMed/NCBI View Article : Google Scholar

Armitage JO, Gascoyne RD, Lunning MA and Cavalli F: Non-Hodgkin lymphoma. Lancet. 390:298–310. 2017.PubMed/NCBI View Article : Google Scholar

Jiang L and Li N: B-cell non-Hodgkin lymphoma: Importance of angiogenesis and antiangiogenic therapy. Angiogenesis. 23:515–529. 2020.PubMed/NCBI View Article : Google Scholar

Gequelin LCF, Riediger IN, Nakatani SM, Biondo AW and Bonfim CM: Epstein-Barr virus: General factors, virus-related diseases and measurement of viral load after transplant. Rev Bras Hematol Hemoter. 33:383–388. 2011.PubMed/NCBI View Article : Google Scholar

Câmara AB and Brandão IA: The non-Hodgkin lymphoma treatment and side effects: A systematic review and meta-analysis. Recent Pat Anticancer Drug Discov: Jan 17, 2023 (Epub ahead of print).

Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A and Ghafouri A: Peripheral lymphadenopathy: Approach and diagnostic tools. Iran J Med Sci. 39 (2 Suppl):S158–S170. 2014.PubMed/NCBI

Pirosa MC and Peccatori FA: Lymphomas in pregnancy. Hematol Oncol. 41 (Suppl 1):S70–S74. 2023.PubMed/NCBI View Article : Google Scholar

Dunleavy K and McLintock C: How I treat lymphoma in pregnancy. Blood. 136:2118–2124. 2020.PubMed/NCBI View Article : Google Scholar

Evens AM, Advani R, Press OW, Lossos IS, Vose JM, Hernandez-Ilizaliturri FJ, Robinson BK, Otis S, Nadav Dagan L, Abdallah R, et al: Lymphoma occurring during pregnancy: Antenatal therapy, complications, and maternal survival in a multicenter analysis. J Clin Oncol. 31:4132–4139. 2013.PubMed/NCBI View Article : Google Scholar

Nooh MM, Rizk SM, Saied NM and Abdelazim SM: Carnosine remedial effect on fertility of male rats receiving cyclophosphamide, hydroxydaunomycin, oncovin and prednisone (CHOP). Andrologia. 53(e14233)2021.PubMed/NCBI View Article : Google Scholar

Antoine-Pepeljugoski C and Braunstein MJ: Management of newly diagnosed elderly multiple myeloma patients. Curr Oncol Rep. 21(64)2019.PubMed/NCBI View Article : Google Scholar

Ribourtout B and Zandecki M: Plasma cell morphology in multiple myeloma and related disorders. Morphologie. 99:38–62. 2015.PubMed/NCBI View Article : Google Scholar

Michels TC and Petersen KE: Multiple myeloma: Diagnosis and treatment. Am Fam Physician. 95:373–383. 2017.PubMed/NCBI

Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D, Fears TR, Hoover RN and Linet MS: Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood. 107:904–906. 2006.PubMed/NCBI View Article : Google Scholar

Kyle RA and Rajkumar SV: Multiple myeloma. N Engl J Med. 351:1860–1873. 2004.PubMed/NCBI View Article : Google Scholar

Kyle RA and Rajkumar SV: Multiple myeloma. Blood. 111:2962–2972. 2008.PubMed/NCBI View Article : Google Scholar

International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the international myeloma working group. Br J Haematol. 121:749–757. 2003.PubMed/NCBI

Kristinsson SY, Minter AR, Korde N, Tan E and Landgren O: Bone disease in multiple myeloma and precursor disease: Novel diagnostic approaches and implications on clinical management. Expert Rev Mol Diagn. 11:593–603. 2011.PubMed/NCBI View Article : Google Scholar

Regelink JC, Minnema MC, Terpos E, Kamphuis MH, Raijmakers PG, Pieters-van den Bos IC, Heggelman BGF, Nievelstein RJ, Otten RHJ, van Lammeren-Venema D, et al: Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: A systematic review. Br J Haematol. 162:50–61. 2013.PubMed/NCBI View Article : Google Scholar

Rajkumar SV: MGUS and smoldering multiple myeloma: Update on pathogenesis, natural history, and management. Hematology Am Soc Hematol Educ Program. 2005:340–345. 2005.PubMed/NCBI View Article : Google Scholar

Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA, et al: International staging system for multiple myeloma. J Clin Oncol. 23:3412–3420. 2005.PubMed/NCBI View Article : Google Scholar

Elgabry G, Spencer L, Siddiqi H, Ojha S and Wandroo F: A report of a symptomatic progressive myeloma during pregnancy and postpartum period from asymptomatic state. Hematol Rep. 15:305–311. 2023.PubMed/NCBI View Article : Google Scholar

Rizack T, Mega A, Legare R and Castillo J: Management of hematological malignancies during pregnancy. Am J Hematol. 84:830–841. 2009.PubMed/NCBI View Article : Google Scholar

de Montalembert M, Ferster A, Colombatti R, Rees DC and Gulbis B: European Network for Rare and Congenital Anaemias. ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children. Am J Hematol. 86:72–75. 2011.PubMed/NCBI View Article : Google Scholar

Kinoshita S, Yamashita K, Iwatsuki M, Sato H, Matsumoto C, Matsumoto T, Shiraishi Y, Yoshida N and Baba H: Disseminated carcinomatosis of the bone marrow from gastric cancer during pregnancy. Clin J Gastroenterol. 12:447–452. 2019.PubMed/NCBI View Article : Google Scholar

Sakamoto K, Kanda T, Ohashi M, Kurabayashi T, Serikawa T, Matsunaga M and Hatakeyama K: Management of patients with pregnancy-associated gastric cancer in Japan: A mini-review. Int J Clin Oncol. 14:392–396. 2009.PubMed/NCBI View Article : Google Scholar

Song MJ, Park YS, Song HJ, Park SJ, Ahn JY, Choi KD, Lee GH, Jung HY, Yook JH and Kim BS: Prognosis of pregnancy-associated gastric cancer: An age-, sex-, and stage-matched case-control study. Gut Liver. 10:731–738. 2016.PubMed/NCBI View Article : Google Scholar

Milojkovic D and Apperley JF: How I treat leukemia during pregnancy. Blood. 123:974–984. 2014.PubMed/NCBI View Article : Google Scholar

Krashin E and Lishner M: Managing leukemia during pregnancy. In: Azim H Jr (ed). Managing Cancer during Pregnancy. Springer, Cham, pp175-184, 2016.

Van Calsteren K, Verbesselt R, Beijnen J, Devlieger R, De Catte L, Chai DC, Van Bree R, Heyns L, de Hoon J and Amant F: Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol. 119:594–600. 2010.PubMed/NCBI View Article : Google Scholar